The biotech start-up Lygos CBx recently announced that it has completed commercial-scale production of its cannabinoid products, including CBG (cannabigerol), CBC (cannabichromene), CBD (cannabidiol), and CBDA (cannabidiolic acid), employing its proprietary fermentation and processing technology.
The Japanese biofabrication startup Spiber has raised JPY 34.4 billion (US$312 million) in a funding round led by local public-private fund Cool Japan Fund and. private equity firm Carlyle. Fund managers Fidelity and Baillie Gifford also contributed to the round.
Swedish firms building a demonstration plant to produce textiles from cellulosic fibres [Full subscriber]
Sweden-based TreeToTextile, owned by H&M Group, Inter IKEA Group, Stora Enso, and LSCS Invest are investing in constructing a demonstration plant in Sweden that uses a novel process to convert wood into a cellulose-based textile fibre.
Engineered microbes produce fibres “outperforming many synthetic and natural polymers” [Full subscriber]
Researchers from Washington State University have developed a synthetic chemistry technology that allows them to polymerize proteins inside engineered microbes to make muscle fibres – a more robust substance than silk or cotton.
Givaudan partners with Ginkgo Bioworks to produce biobased ingredients for the flavours and fragrances sectors [Full subscriber]
The Swiss flavour and fragrance giant Givaudan is partnering with synthetic biology platform company Ginkgo Bioworks to develop a new series of biobased ingredients.
Lulumelon invests in Genomatica’s technology to use biobased BDO in its apparel offerings [Full subscriber]
The fitness apparel giant Lululemon recently announced a multi-year collaboration with Genomatica whereby it will use biobased materials produced via Genomatica’s technology in its products.
Biotech start-ups LanzaTech and Twelve have partnered to transform carbon dioxide into polypropylene, a key polymer used for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles and other everyday products.
Biosyntia partners with Givaudan to produce natural flavour ingredients from sugar [Full subscriber]
The Danish biotech start-up Biosyntia, with the expertise in the development of fermentation processes for select small molecules, has entered into a multi-year collaboration with Givaudan, a supplier of flavours, taste, functional and nutritional solutions to develop and manufacture sustainable, natural ingredients for food and beverage sectors.
Solugen secures US$357 million to produce chemicals from sugar via “chemienzymatic” process [Registered]
The biotech start-up Solugen has raised US$357 million from investors to produce substitute petrochemicals from converting sugars into chemicals using both enzyme and chemical catalysts.